"India is generally perceived to be a self-pay market. While it is predominantly a self-pay market, there are institutions that reimburse either in a direct or…
In Conversation
"The overall mission is to ensure that majority of Indian patients benefit from the Takeda’s innovative medicines in a sustainable manner."
"Despite of the Agency’s smallness we have earned the recognition in the comparative measurements of European agencies of medicines, and the professionalism of our employees and…
"What J&J Medical Devices is seeking is not only present our own products but provide a more holistic view that involves the key decision makers from…
"In a country like India where the vast majority of people live in rural areas and where millions live on less than USD 2 a day,…
"Our established footprint in the Estonian pharmaceutical market is primarily due to two factors: our products and our people."
"Our aim is to provide complete services from the first stage of development to the end product and represent a one stop shop for our customers."
"As a small country, I believe it is much more lucrative to focus on exports and on attracting foreign investment rather than merely focusing on the…
"A large percentage of the production cost is materials, and although Poland is not the cheapest, a huge focus of ours is to ensure high-quality."
"Our main focus will be in oncology and rolling out FMI services including Artificial Intelligence so as to differentiate patient needs and enable targeted therapies."
"The Polish dermo-cosmetic market is a promising market and offers great potential for development as it makes up less than five-percent of overall cosmetic sales."
"The ease of market access and the overall process is significantly longer in Estonia than in countries like Sweden or Denmark, but it has worked out…
